Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4177212
Max Phase: Preclinical
Molecular Formula: C68H122N18O18
Molecular Weight: 1479.83
Molecule Type: Small molecule
Associated Items:
ID: ALA4177212
Max Phase: Preclinical
Molecular Formula: C68H122N18O18
Molecular Weight: 1479.83
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCC[C@@H](CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)C[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)C[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(C)=O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)CC
Standard InChI: InChI=1S/C68H122N18O18/c1-11-15-21-42(30-55(93)76-43(22-16-18-27-69)61(97)81-48(60(73)96)31-53(72)91)75-64(100)49(35-87)83-68(104)59(40(9)14-4)85-57(95)34-74-54(92)32-46(37(5)6)79-65(101)50(36-88)82-63(99)45(25-26-52(71)90)78-67(103)58(39(8)13-3)84-56(94)33-47(38(7)12-2)80-62(98)44(23-17-19-28-70)77-66(102)51-24-20-29-86(51)41(10)89/h37-40,42-51,58-59,87-88H,11-36,69-70H2,1-10H3,(H2,71,90)(H2,72,91)(H2,73,96)(H,74,92)(H,75,100)(H,76,93)(H,77,102)(H,78,103)(H,79,101)(H,80,98)(H,81,97)(H,82,99)(H,83,104)(H,84,94)(H,85,95)/t38-,39-,40-,42-,43-,44-,45-,46+,47+,48-,49-,50-,51-,58-,59-/m0/s1
Standard InChI Key: MVOBDVSNKIKGIO-YCFIPHDZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1479.83 | Molecular Weight (Monoisotopic): 1478.9184 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. de Lucio H, Gamo AM, Ruiz-Santaquiteria M, de Castro S, Sánchez-Murcia PA, Toro MA, Gutiérrez KJ, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.. (2017) Improved proteolytic stability and potent activity against Leishmania infantum trypanothione reductase of α/β-peptide foldamers conjugated to cell-penetrating peptides., 140 [PMID:29017116] [10.1016/j.ejmech.2017.09.032] |
Source(1):